Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de Harry Werner Kirsch
Age : 55
Public asset : 29,029,579 USD
Country of residence : Unknown
Linked companies : Novartis AG

Biography of Harry Werner Kirsch 
Currently, Harry Werner Kirsch is Chief Financial Officer for Novartis AG. Mr. Kirsch is also on the board of 5 other companies. In the past Mr. Kirsch occupied the position of CFO-Global Pharmaceutical Business at Procter & Gamble Co. Mr. Kirsch received an undergraduate degree from Karlsruher Institut fŘr Technologie.


Current positions of Harry Werner Kirsch 
Holdings of Harry Werner Kirsch 
Harry Werner Kirsch : Personal Network 
Most Read News 
08/02JACK DORSEY : Twitter's Dorsey leads $29 billion buyout of lending pioneer Afterpay
RE
07/28MARK ZUCKERBERG : Facebook's slowdown warning hangs over strong ad sales, while Zuckerberg talks 'metaverse'
RE
07/20JEFF BEZOS : billionaire Bezos has successful suborbital jaunt
RE
07/26JEFF BEZOS : Bezos-backed plant food firm NotCo joins unicorn club after latest funding
RE
07/26MICHAEL KLEIN : EV maker Lucid rises in Nasdaq debut after merger with Klein-backed SPAC
RE
07/27RAJESH KUMAR : GE warns of inflationary pressure after lifting cash flow estimate
RE
07/26JEFF BEZOS : Bezos offers NASA $2 billion in exchange for moon mission contract
RE
07/27IAN READ : Exclusive-Rivian ready to invest $5 billion in second U.S. assembly plant -document
RE
07/29TREVOR MILTON : U.S. charges Nikola founder Trevor Milton with lying to investors
RE
07/22RYAN COHEN : Flush from Reddit rally, GameStop plots store revival
RE
More news


© 2021 People and Ownership :   
Harry Werner Kirsch : Connections 


Latest news about Harry Werner Kirsch 
07/21Novartis tops forecasts as crisis impact eases
RE
07/21NOVARTIS : profit tops expectations as pandemic impact ebbs
RE
2020Novartis upbeat as drugmakers see hospitals coping with COVID
RE
2020Novartis upbeat as drugmakers see hospitals coping with COVID
RE
2020NOVARTIS : aims to expand Beovu use after safety fears hurt launch
RE
2020NOVARTIS : aims to expand Beovu use after safety fears hurt launch
RE
More news